503a retatrutide GLP-3 (RT) Retatrutide (GLP-3) – Y&P Labs

Total Cost Analysis: Calculate cost per unit at your target order volume, not just the listed price range

Abstract Lixisenatide (AVE0010) is a once-daily glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes

These two peptides target overlapping but distinct stages of the tissue repair process, making their combination more effective than either used alone

Concentration 100 units/mL Vials per package 1 vial Volume per vial 10 mL Units of insulin per vial 1000 units NDC number 0169-2662-11 Concentration 100 units/mL Vials per package 1 vial Volume per vial 10 mL Units of insulin per vial 1000 units NDC number 0169-2662-11 An option for patients who prefer vials or children who require fewer than 5 units a day